JOHANNESBURG, South Africa, Sept. 25 -- The University of the Witwatersrand issued the following news: * * * Landmark agreement to make HIV prevention tool lenacapavir affordable in LMICs Unitaid, CHAI, and Wits RHI agreement with Dr. Reddy's to make revolutionary injectable available at a cost of US$40 a year in 120 LMICs starting in 2027. * Under a new partnership announced on 24 September 2025 between Dr. Reddy's Laboratories and Unitaid, the Clinton Health Access Initiative (CHAI), and Wits RHI, lenacapavir will be available in 120 low more PR